Page last updated: 2024-08-21

isoxazoles and tg101209

isoxazoles has been researched along with tg101209 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abhyankar, S; Balusu, R; Bhalla, KN; Fiskus, W; Ha, K; Hembruff, SL; Manshouri, T; McGuirk, J; Rao, NN; Rao, R; Smith, JE; Venkannagari, S; Verstovsek, S	1

Other Studies

1 other study(ies) available for isoxazoles and tg101209

Article	Year
Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-01, Volume: 17, Issue:23 Topics: Animals; Antigens, CD34; Apoptosis; bcl-X Protein; Cell Cycle; Drug Resistance, Neoplasm; Drug Synergism; Hematopoietic Stem Cells; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Janus Kinase 2; Mice; Myeloproliferative Disorders; Proto-Oncogene Proteins c-akt; Pyrimidines; Resorcinols; Signal Transduction; STAT5 Transcription Factor; Sulfonamides; Tumor Cells, Cultured	2011

Article

Year

Heat shock protein 90 inhibitor is synergistic with JAK2 inhibitor and overcomes resistance to JAK2-TKI in human myeloproliferative neoplasm cells.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-01, Volume: 17, Issue:23

Topics: Animals; Antigens, CD34; Apoptosis; bcl-X Protein; Cell Cycle; Drug Resistance, Neoplasm; Drug Synergism; Hematopoietic Stem Cells; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Janus Kinase 2; Mice; Myeloproliferative Disorders; Proto-Oncogene Proteins c-akt; Pyrimidines; Resorcinols; Signal Transduction; STAT5 Transcription Factor; Sulfonamides; Tumor Cells, Cultured

2011